Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/22/2022 | $34.00 → $24.00 | Outperform | Wedbush |
| 2/11/2022 | $19.00 | Buy | Goldman Sachs |
Wedbush reiterated coverage of Codiak BioSciences with a rating of Outperform and set a new price target of $24.00 from $34.00 previously
Goldman Sachs initiated coverage of Codiak BioSciences with a rating of Buy and set a new price target of $19.00
25-NSE - Codiak BioSciences, Inc. (0001659352) (Subject)
NT 10-K - Codiak BioSciences, Inc. (0001659352) (Filer)
8-K - Codiak BioSciences, Inc. (0001659352) (Filer)